Petter Bjornstad1, Lori Laffel2, Jane Lynch3, Laure El Ghormli4, Ruth S Weinstock5, Sherida E Tollefsen6, Kristen J Nadeau1. 1. University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO. 2. Joslin Diabetes Center, Boston, MA. 3. The University of Texas Health Science Center at San Antonio, San Antonio, TX. 4. George Washington University Biostatistics Center, Rockville, MD elghorml@bsc.gwu.edu. 5. Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY. 6. Department of Pediatrics, Saint Louis University Health Sciences Center, St. Louis, MO.
Abstract
OBJECTIVE: Elevated serum uric acid (SUA) is increasingly recognized as a risk factor for kidney disease in adults with diabetes, but data in youth are limited. We hypothesized that elevated SUA predicts development of elevated urinary albumin excretion (UAE) and hypertension over time in teens with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: Serum creatinine, cystatin C, SUA, and the urine albumin-to-creatinine ratio (UACR) were assessed in 539 obese youth, ages 12-17 years, with T2D duration <2 years at baseline in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study. Estimated glomerular filtration rate (eGFR) was calculated using creatinine and cystatin C. Hypertension was defined as systolic or diastolic blood pressure ≥130/80 mmHg and elevated UAE as UACR ≥30 mg/g. Cox proportional hazards models evaluated the relationship between SUA and outcome variables longitudinally over an average follow-up of 5.7 years, adjusting for age, sex, race/ethnicity, BMI, HbA1c, eGFR, ACE inhibitor/angiotensin receptor blocker use, and TODAY treatment group assignment. RESULTS: At baseline, hyperuricemia (≥6.8 mg/dL) was present in 25.6% of participants, hypertension in 18.7%, and elevated UAE in 6.1%. During follow-up of up to 7 years, hypertension developed in 37.4% and UAE in 18.0%. Higher baseline SUA increased the risk of incident hypertension (hazard ratio [HR] 1.19, 95% CI 1.03-1.38, per 1 mg/dL increase in SUA) and elevated UAE (HR 1.24, 95% CI 1.03-1.48) in adjusted models. CONCLUSIONS: Hyperuricemia was common in youth with T2D. Higher baseline SUA independently increased the risk for onset of hypertension and elevated UAE. Research is needed to determine whether SUA-lowering therapies can impede development of diabetic kidney disease and hypertension in T2D youth.
OBJECTIVE: Elevated serum uric acid (SUA) is increasingly recognized as a risk factor for kidney disease in adults with diabetes, but data in youth are limited. We hypothesized that elevated SUA predicts development of elevated urinary albumin excretion (UAE) and hypertension over time in teens with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: Serum creatinine, cystatin C, SUA, and the urine albumin-to-creatinine ratio (UACR) were assessed in 539 obese youth, ages 12-17 years, with T2D duration <2 years at baseline in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study. Estimated glomerular filtration rate (eGFR) was calculated using creatinine and cystatin C. Hypertension was defined as systolic or diastolic blood pressure ≥130/80 mmHg and elevated UAE as UACR ≥30 mg/g. Cox proportional hazards models evaluated the relationship between SUA and outcome variables longitudinally over an average follow-up of 5.7 years, adjusting for age, sex, race/ethnicity, BMI, HbA1c, eGFR, ACE inhibitor/angiotensin receptor blocker use, and TODAY treatment group assignment. RESULTS: At baseline, hyperuricemia (≥6.8 mg/dL) was present in 25.6% of participants, hypertension in 18.7%, and elevated UAE in 6.1%. During follow-up of up to 7 years, hypertension developed in 37.4% and UAE in 18.0%. Higher baseline SUA increased the risk of incident hypertension (hazard ratio [HR] 1.19, 95% CI 1.03-1.38, per 1 mg/dL increase in SUA) and elevated UAE (HR 1.24, 95% CI 1.03-1.48) in adjusted models. CONCLUSIONS:Hyperuricemia was common in youth with T2D. Higher baseline SUA independently increased the risk for onset of hypertension and elevated UAE. Research is needed to determine whether SUA-lowering therapies can impede development of diabetic kidney disease and hypertension in T2D youth.
Authors: Todd S Perlstein; Olga Gumieniak; Paul N Hopkins; Laine J Murphey; Nancy J Brown; Gordon H Williams; Norman K Hollenberg; Naomi D L Fisher Journal: Kidney Int Date: 2004-10 Impact factor: 10.612
Authors: Hans Pottel; Liesbeth Hoste; Laurence Dubourg; Natalie Ebert; Elke Schaeffner; Bjørn Odvar Eriksen; Toralf Melsom; Edmund J Lamb; Andrew D Rule; Stephen T Turner; Richard J Glassock; Vandréa De Souza; Luciano Selistre; Christophe Mariat; Frank Martens; Pierre Delanaye Journal: Nephrol Dial Transplant Date: 2016-02-29 Impact factor: 5.992
Authors: David M Maahs; Luiza Caramori; David Z I Cherney; Andrzej T Galecki; Chuanyun Gao; Diana Jalal; Bruce A Perkins; Rodica Pop-Busui; Peter Rossing; Michael Mauer; Alessandro Doria Journal: Curr Diab Rep Date: 2013-08 Impact factor: 4.810
Authors: Helen C Looker; Laura Pyle; Tim Vigers; Cameron Severn; Pierre J Saulnier; Behzad Najafian; Michael Mauer; Robert G Nelson; Petter Bjornstad Journal: Diabetes Care Date: 2022-02-01 Impact factor: 19.112
Authors: Kalie L Tommerdahl; Petter Bjornstad; Jessica Kendrick; Melanie Cree-Green; Amy D Baumgartner; Laura Pyle; Jane E B Reusch; Kristen J Nadeau Journal: Diabetes Obes Metab Date: 2020-12-23 Impact factor: 6.577
Authors: S Christopher Derderian; Luke Patten; Alexander M Kaizer; Jaime M Moore; Sarah Ogle; Todd M Jenkins; Marc P Michalsky; James E Mitchell; Petter Bjornstad; John B Dixon; Thomas H Inge Journal: Obesity (Silver Spring) Date: 2020-12 Impact factor: 5.002
Authors: Kalie L Tommerdahl; Karl Baumgartner; Michal Schäfer; Petter Bjornstad; Isabella Melena; Shannon Hegemann; Amy D Baumgartner; Laura Pyle; Melanie Cree-Green; Uyen Truong; Lorna Browne; Judith G Regensteiner; Jane E B Reusch; Kristen J Nadeau Journal: Diabetes Care Date: 2021-01-05 Impact factor: 19.112
Authors: Guozhi Jiang; Andrea O Luk; Claudia H T Tam; Risa Ozaki; Cadmon K P Lim; Elaine Y K Chow; Eric S Lau; Alice P S Kong; Baoqi Fan; Ka Fai Lee; Shing Chung Siu; Grace Hiu; Chiu Chi Tsang; Kam Piu Lau; Jenny Y Leung; Man-wo Tsang; Grace Kam; Ip Tim Lau; June K Li; Vincent T Yeung; Emmy Lau; Stanley Lo; Samuel Fung; Yuk Lun Cheng; Chun Chung Chow; Nelson L S Tang; Yu Huang; Hui-yao Lan; Richard A Oram; Cheuk Chun Szeto; Wing Yee So; Juliana C N Chan; Ronald C W Ma Journal: Diabetes Date: 2022-03-01 Impact factor: 9.461
Authors: Y Qin; S Zhang; S Cui; X Shen; J Wang; X Cui; M Zuo; Z Gao; J Zhang; J Yang; H Zhu; B Chang Journal: J Endocrinol Invest Date: 2021-01-29 Impact factor: 4.256